Key result
The anticoagulant fraction of incubated fibrinogen competitively inhibits the action of thrombin on fibrinogen, an effect abolished by heating above 55°C and modulated by pH and divalent cations.
Population
In vitro biochemical model studying the anticoagulant fraction of incubated fibrinogen, thrombin, and…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for fibrinogen-derived thrombin inhibitors; requires human validation before clinical consideration.
The anticoagulant fraction of incubated fibrinogen competitively inhibits thrombin action on fibrinogen, with properties distinct from heparin and sensitivity to heat and pH.
D. C. Triantaphyllopoulos (1959) studied this question. Anticoagulant fraction of incubated fibrinogen (AFIF) was evaluated on Thrombin-inhibiting activity. The anticoagulant fraction of incubated fibrinogen competitively inhibits the action of thrombin on fibrinogen, an effect abolished by heating above 55°C and modulated by pH and divalent cations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: